Keywords: Acorda Thera, Ampyra, Seizure risk, USA. FDA, Multiple sclerosis

US FDA points to seizure risk with Acorda's MS drug Ampyra

Article | 25 July 2012

Print This

The US Food and Drug Administration has issued a warning about the risk of seizures in patients with multiple sclerosis ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in